LICENSE AGREEMENT FOR INTERFERON GAMMALicense Agreement • May 26th, 2017 • Horizon Pharma PLC • Pharmaceutical preparations • California
This Agreement is entered into effective as of May 5, 1998, (“Effective Date”) by and between Connetics Corporation, a Delaware corporation with its principal office at 3400 West Bayshore Road, Palo Alto, California 94303 (“Connetics”), and Genentech, Inc., a Delaware corporation with its principal office at 1 DNA Way, South San Francisco, California 94080 (“Genentech”).
AMENDMENT NO. THREE TO LICENSE AGREEMENTLicense Agreement • May 26th, 2017 • Horizon Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NUMBER THREE TO LICENSE AGREEMENT FOR INTERFERON GAMMA (“Amendment”) is entered into effective April 27, 1999 (the “Amendment Effective Date”), by and between Genentech, Inc. (“Genentech”) and Connetics Corporation (“Connetics”). Genentech and Connetics may each be referred to herein as a “Party” and jointly as the “Parties.”
